BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8281875)

  • 1. Omeprazole ameliorates aspirin-induced gastroduodenal injury.
    Scheiman JM; Behler EM; Loeffler KM; Elta GH
    Dig Dis Sci; 1994 Jan; 39(1):97-103. PubMed ID: 8281875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole taken once every other day can effectively prevent aspirin-induced gastrointestinal mucosal damage in rats.
    Weng J; Song Y; Kuai D; Dai W; Yao Y; Xu W; Li Y; Fan L; Xu B
    BMC Gastroenterol; 2024 May; 24(1):187. PubMed ID: 38811868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in
    Chitapanarux T; Lertprasertsuke N; Kongnak A
    Scand J Gastroenterol; 2019 Oct; 54(10):1199-1204. PubMed ID: 31591940
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study.
    Sartori S; Trevisani L; Nielsen I; Tassinari D; Abbasciano V
    Cancer; 1996 Oct; 78(7):1477-82. PubMed ID: 8839554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.
    McAlindon ME; Muller AF; Filipowicz B; Hawkey CJ
    Gut; 1996 Apr; 38(4):518-24. PubMed ID: 8707080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abolition by omeprazole of aspirin induced gastric mucosal injury in man.
    Daneshmend TK; Stein AG; Bhaskar NK; Hawkey CJ
    Gut; 1990 May; 31(5):514-7. PubMed ID: 2190865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen.
    Oddsson E; Gudjónsson H; Thjódleifsson B
    Scand J Gastroenterol; 1992 Dec; 27(12):1045-8. PubMed ID: 1475621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Yeomans ND
    Am J Med; 1998 Mar; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R; Armstrong D
    Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects.
    Dorta G; Nicolet M; Vouillamoz D; Margalith D; Saraga E; Bouzourene H; Häcki WH; Stolte M; Blum AL; Armstrong D
    Aliment Pharmacol Ther; 2000 May; 14(5):535-41. PubMed ID: 10792115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk -- a single-blind, randomized controlled study.
    Ng FH; Wong BC; Wong SY; Chen WH; Chang CM
    Aliment Pharmacol Ther; 2004 Feb; 19(3):359-65. PubMed ID: 14984383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa.
    Hoftiezer JW; O'Laughlin JC; Ivey KJ
    Gut; 1982 Aug; 23(8):692-7. PubMed ID: 7095565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
    Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing and prevention of NSAID-induced peptic ulcers.
    Hawkey CJ
    Scand J Gastroenterol Suppl; 1994; 201():42-4. PubMed ID: 8047823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID-induced peptic ulcer disease: a critical review of pathogenesis and management.
    Scheiman JM
    Dig Dis; 1994; 12(4):210-22. PubMed ID: 7851000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.